ArticleJournal for immunotherapy of cancer2019

Severe early hepatitis B reactivation in a patient receiving anti-CD19 and anti-CD22 CAR T cells for the treatment of diffuse large B-cell lymphoma.

Jia Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.